Citation: Pm. Hoff et al., UFT AND LEUCOVORIN - A REVIEW OF ITS CLINICAL DEVELOPMENT AND THERAPEUTIC POTENTIAL IN THE ORAL TREATMENT OF CANCER, Anti-cancer drugs, 9(6), 1998, pp. 479-490
Citation: A. Sulkes et al., URACIL-FTORAFUR - AN ORAL FLUOROPYRIMIDINE ACTIVE IN COLORECTAL-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3461-3475
Authors:
LIPPMAN SM
BENNER SE
FRITSCHE HA
LEE JS
HONG WK
Citation: Sm. Lippman et al., THE EFFECT OF 13-CIS-RETINOIC ACID CHEMOPREVENTION ON HUMAN SERUM RETINOL LEVELS, Cancer detection and prevention, 22(1), 1998, pp. 51-56
Authors:
HUBER MH
LIPPMAN SM
BENNER SE
SHIRINIAN M
DIMERY IW
DUNNINGTON JS
HONG WK
Citation: Mh. Huber et al., A PHASE-II STUDY OF IFOSFAMIDE IN RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, American journal of clinical oncology, 19(4), 1996, pp. 379-383
Authors:
HUBER MH
LIPPMAN SM
BENNER SE
SHIRINIAN M
DIMERY IW
EARLY CL
WINN RJ
BROOKS J
BAEZ L
HONG WK
Citation: Mh. Huber et al., PHASE-II STUDY OF CARBOPLATIN AND CONTINUOUS-INFUSION BLEOMYCIN FOLLOWED BY CISPLATIN AND 5-FLUOROURACIL IN RECURRENT HEAD AND NECK-CANCER, Annals of oncology, 6(1), 1995, pp. 83-85
Citation: Se. Benner et al., PHASE-I STUDY OF PACLITAXEL, CISPLATIN, AND IFOSFAMIDE IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CANCER OF THE HEAD AND NECK, Seminars in oncology, 22(5), 1995, pp. 22-25
Authors:
BENNER SE
PAJAK TF
STETZ J
LIPPMAN SM
HONG WK
SCHANTZ SP
GALLAGHER MJ
SHENOUDA G
Citation: Se. Benner et al., TOXICITY OF ISOTRETINOIN IN A CHEMOPREVENTION TRIAL TO PREVENT 2ND PRIMARY TUMORS FOLLOWING HEAD-AND-NECK-CANCER, Journal of the National Cancer Institute, 86(23), 1994, pp. 1799-1801
Authors:
BENNER SE
PAJAK TF
LIPPMAN SM
EARLEY C
HONG WK
Citation: Se. Benner et al., PREVENTION OF 2ND PRIMARY TUMORS WITH ISOTRETINOIN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - LONG-TERM FOLLOW-UP, Journal of the National Cancer Institute, 86(2), 1994, pp. 140-141
Authors:
BENNER SE
WARGOVICH ML
LIPPMAN SM
FISHER R
VELASCO M
WINN RJ
HONG WK
Citation: Se. Benner et al., REDUCTION IN ORAL-MUCOSA MICRONUCLEI FREQUENCY FOLLOWING ALPHA-TOCOPHEROL TREATMENT OF ORAL LEUKOPLAKIA, Cancer epidemiology, biomarkers & prevention, 3(1), 1994, pp. 73-76
Citation: Se. Benner et al., CHEMOPREVENTION OF 2ND PRIMARY TUMORS - A MODEL FOR INTERVENTION TRIALS, European journal of cancer, 30A(6), 1994, pp. 727-729
Citation: Wk. Hong et al., EVOLUTION OF AERODIGESTIVE TRACT 13-CIS-RETINOID ACID CHEMOPREVENTION- THE ANDERSON,M.D. EXPERIENCE, Leukemia, 8, 1994, pp. 33-37
Citation: Se. Benner et al., A STOPPING RULE FOR STANDARD CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - LESSONS FROM A SURVEY OF MARYLAND MEDICAL ONCOLOGISTS, Cancer investigation, 12(5), 1994, pp. 451-455
Authors:
LEE JS
LIPPMAN SM
BENNER SE
LEE JJ
RO JY
LUKEMAN JM
MORICE RC
PETERS EJ
PANG AC
FRITSCHE HA
HANG WK
Citation: Js. Lee et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ISOTRETINOIN IN CHEMOPREVENTION OF BRONCHIAL SQUAMOUS METAPLASIA, Journal of clinical oncology, 12(5), 1994, pp. 937-945
Authors:
HUBER MH
DIMERY IW
BENNER SE
LIPPMAN SM
SHIRINIAN M
ESPARAZ B
FRENNING D
GUILLORYPEREZ C
HONG WK
Citation: Mh. Huber et al., PHASE-II STUDY OF CARBOPLATIN AND EDATREXATE (10-EDAM) WITH LEUCOVORIN RESCUE FOR PATIENTS WITH RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Investigational new drugs, 12(4), 1994, pp. 327-331
Authors:
BENNER SE
LIPPMAN SM
WARGOVICH MJ
LEE JJ
VELASCO M
MARTIN JW
TOTH BB
HONG WK
Citation: Se. Benner et al., MICRONUCLEI, A BIOMARKER FOR CHEMOPREVENTION TRIALS - RESULTS OF A RANDOMIZED STUDY IN ORAL PRE-MALIGNANCY, International journal of cancer, 59(4), 1994, pp. 457-459
Citation: Sm. Lippman et al., RETINOID CHEMOPREVENTION STUDIES IN UPPER AERODIGESTIVE TRACT AND LUNG CARCINOGENESIS, Cancer research, 54(7), 1994, pp. 190002025-190002028
Citation: Se. Benner et Wk. Hong, CLINICAL CHEMOPREVENTION - DEVELOPING A CANCER PREVENTION STRATEGY, Journal of the National Cancer Institute, 85(18), 1993, pp. 1446-1447